International Commission to Expand Molecular Testing Access for Cancer Patients

The University of Glasgow said on Tuesday that it will lead a new commission dedicated to improving global access to diagnostic tests and personalized cancer care.

The International Cancer Genome Consortium’s Accelerating Research in Genomic Oncology (ICGC ARGO) initiative, which is spearheading an effort to analyze specimens from 100,000 cancer patients, will coordinate the commission’s work. Other participating organizations include the European Society for Medical Oncology, International Agency for Research on Cancer, Latin American Cooperative Oncology Group, African Organization for Research and Training in Cancer, Asian Oncology Society, Global Alliance for Genomics and Health, International Quality Network for Pathology, and US Food and Drug Administration.